Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Supplementation for Cognitive Function in Depression
NCT07521358Completed
- Sponsor
- Hasanuddin University
- Start
- Jul 2025
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial in major depressive disorder (MDD) (2 arms), sponsored by Hasanuddin University. Primary endpoint: Montreal Cognitive Assessment at 6 weeks. Started Jul 2025; status: completed.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07521358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07521358.